Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin… Grant US-11925626-B2 United States of America 12 Mar 2024
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid… Grant US-11684612-B2 United States of America 27 Jun 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Grant US-11648245-B2 United States of America 16 May 2023
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid… Grant US-11590113-B2 United States of America 28 Feb 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Grant US-11576907-B2 United States of America 14 Feb 2023
Methods of treating castration-resistant prostate cancer with glucocorticoid receptor… Grant US-11564932-B2 United States of America 31 Jan 2023
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin… Grant US-11464764-B2 United States of America 11 Oct 2022
Methods of treating cancer comprising administration of a glucocorticoid receptor… Grant US-11389432-B2 United States of America 19 Jul 2022
Methods of treating cancer comprising administration of a glucocorticoid receptor… Grant US-11234971-B2 United States of America 01 Feb 2022
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid… Grant US-11058670-B2 United States of America 13 Jul 2021
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Grant US-10973813-B2 United States of America 13 Apr 2021
Methods of treating castration-resistant prostate cancer with glucocorticoid receptor… Grant US-10729699-B2 United States of America 04 Aug 2020
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Grant US-10456392-B2 United States of America 29 Oct 2019
Methods of treating castration-resistant prostate cancer with glucocorticoid receptor… Grant US-10300076-B2 United States of America 28 May 2019
Method of treatment for prostate cancer with androgen receptor antagonists and… Grant US-9801893-B2 United States of America 31 Oct 2017